Literature DB >> 8463260

Mutations within the nucleotide binding site of immunoglobulin-binding protein inhibit ATPase activity and interfere with release of immunoglobulin heavy chain.

J R Gaut1, L M Hendershot.   

Abstract

Immunoglobulin-binding protein (BiP), a 70-kDa heat shock protein in the endoplasmic reticulum, binds transiently to nascent proteins, releasing them upon folding and assembly. The in vitro release of bound proteins from BiP requires ATP hydrolysis. Recently, the three-dimensional structure was solved for an ATP-hydrolyzing proteolytic 44-kDa fragment of a 71-kDa heat shock cognate protein, HSC71. Because of the high degree of homology in this region, BiP presumably forms a similar ATP binding structure. Amino-terminal deletions in BiP eliminated ATP-agarose binding. Alteration of a second potential ATP binding site had no effect, suggesting that only the HSC71-like site was capable of ATP binding. Crystallographic data from HSC71 implicated certain amino acids in interactions with the beta-phosphate, gamma-phosphate, and divalent cation of ATP. Mutation of each corresponding residue in BiP (Thr-37, Thr-229, and Glu-201) severely inhibited its ATPase activity. These BiP mutants were still capable of binding ATP and immunoglobulin heavy chains, suggesting that these mutations did not drastically alter the structure of BiP. They did however block the ATP-mediated release of heavy chains from BiP. Our results demonstrate that the structure of BiP in this region must be extremely similar to that elucidated for HSC71 and that mutations of residues proposed to interact with ATP block the ATP-mediated release of bound protein by inhibiting ATP hydrolysis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8463260

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  ERdj3, a stress-inducible endoplasmic reticulum DnaJ homologue, serves as a cofactor for BiP's interactions with unfolded substrates.

Authors:  Ying Shen; Linda M Hendershot
Journal:  Mol Biol Cell       Date:  2004-11-03       Impact factor: 4.138

2.  Fold up or perish: unfolded protein response and chemotherapy.

Authors:  A Strasser; H Puthalakath
Journal:  Cell Death Differ       Date:  2007-11-30       Impact factor: 15.828

3.  BiP mutants that are unable to interact with endoplasmic reticulum DnaJ proteins provide insights into interdomain interactions in BiP.

Authors:  Walid Awad; Isaac Estrada; Ying Shen; Linda M Hendershot
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-18       Impact factor: 11.205

Review 4.  BiP (GRP78), an essential hsp70 resident protein in the endoplasmic reticulum.

Authors:  I G Haas
Journal:  Experientia       Date:  1994-11-30

5.  Physiological modulation of BiP activity by trans-protomer engagement of the interdomain linker.

Authors:  Steffen Preissler; Joseph E Chambers; Ana Crespillo-Casado; Edward Avezov; Elena Miranda; Juan Perez; Linda M Hendershot; Heather P Harding; David Ron
Journal:  Elife       Date:  2015-10-16       Impact factor: 8.140

6.  Proteomic assessment shows that many endoplasmic reticulum (ER)-resident proteins are targeted by N(epsilon)-lysine acetylation in the lumen of the organelle and predicts broad biological impact.

Authors:  Mariana Pehar; Massimiliano Lehnus; Anna Karst; Luigi Puglielli
Journal:  J Biol Chem       Date:  2012-05-24       Impact factor: 5.157

7.  Dissection of structural and functional requirements that underlie the interaction of ERdj3 protein with substrates in the endoplasmic reticulum.

Authors:  Joel H Otero; Beata Lizák; Matthias J Feige; Linda M Hendershot
Journal:  J Biol Chem       Date:  2014-08-20       Impact factor: 5.157

8.  The large Hsp70 Grp170 binds to unfolded protein substrates in vivo with a regulation distinct from conventional Hsp70s.

Authors:  Julia Behnke; Linda M Hendershot
Journal:  J Biol Chem       Date:  2013-12-10       Impact factor: 5.157

9.  Inhibition of immunoglobulin folding and secretion by dominant negative BiP ATPase mutants.

Authors:  L Hendershot; J Wei; J Gaut; J Melnick; S Aviel; Y Argon
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

10.  Regulation of PERK signaling and leukemic cell survival by a novel cytosolic isoform of the UPR regulator GRP78/BiP.

Authors:  Min Ni; Hui Zhou; Shiuan Wey; Peter Baumeister; Amy S Lee
Journal:  PLoS One       Date:  2009-08-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.